Transcatheter Technologies says it's landed the 2nd tranche in its Series B funding round, taking its total raise to more than $7 million for its Trinity replacement heart valve.
Transcatheter Technologies GmbH said it raised the 2nd tranche in its Series B round for its 3rd-generation replacement heart valve.
The tranche takes the German transcatheter aortic heart implant developer's total raise to nearly $7.2 million, a spokesman told MassDevice.com this morning.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nYmDRA
Cap comentari:
Publica un comentari a l'entrada